David Benito Laorga’s Haemophilia Team Hosts Hemosfera
David Benito Laorga, Business Unit Director and Management Team Member Novo Nordisk Spanish Affiliate, shared on LinkedIn:
”This weekend, our haemophilia team hosted Hemosfera, a truly innovative meeting centered on a new treatment with the potential to reduce treatment burden, improve quality of life, and open new possibilities for patients and families.
I’m especially proud of the team behind the scenes.
From concept to execution, this event was powered by strong ownership, deep commitment, and a shared conviction that meaningful innovation requires doing things differently—and doing them well.
This is what high-performing teams look like.
My sincere thanks as well to all the speakers for the depth and quality of the discussions.
Your insights and engagement were critical to making this a truly valuable and impactful event.
Proud of the team. Motivated by the impact we can create for patients.”
Stay updated with Hemostasis Today.
-
Feb 2, 2026, 09:49Tichakunda Mharazanye: A New Year, New Challenges, And New Milestones
-
Feb 2, 2026, 09:16Eyiuche Ezigbo Calls for Stronger VWD Awareness and Better Care in LMICs
-
Feb 2, 2026, 09:04Nicolas de Prost։ Plasma Exchange in Severe ANCA-Associated Vasculitis With DAH
-
Feb 2, 2026, 08:56Bartosz Hudzik on Cancer With ACS: Big Step Forward for Cardio-Oncology
-
Feb 2, 2026, 08:35Karine Kocharian on Armenia-Led WHA Resolution on Hemophilia at WHO Executive Board
-
Feb 2, 2026, 07:12The 2026 Application Cycle for ASH’s International Outreach Initiative is Now Open – ASH
-
Feb 1, 2026, 13:32Shiny K. Kajal: A Series On Reaching the Diagnosis of Immune Thrombocytopenia
-
Feb 1, 2026, 13:26Mary Cushman: Association of Atrial Fibrillation with Risk of Incident Cognitive Impairment
-
Feb 1, 2026, 13:23Abdulrahman Katib: Extended Low-Dose DOAC May Reduce VTE Recurrence